Breaking News Instant updates and real-time market news.

AAPL

Apple

$160.86

-0.64 (-0.40%)

, AVGO

Broadcom

$247.14

-0.6 (-0.24%)

07:23
09/13/17
09/13
07:23
09/13/17
07:23

Apple new iPhone 8/X launch largely in-line with expectations, says KeyBanc

KeyBanc analyst John Vinh says that the incremental features and enhancements associated with the new Apple (AAPL) iPhones announced are largely in-line with expectations. The analyst points out that Apple announced three new phones, with key features including facial identification, removal of the home button on the iPhone X, wireless charging, and fast charging. Vihn sees the new phone launch as most positive for Broadcom (AVGO), Cypress Semiconductor (CY), Integrated Device (IDTI), and Skyworks (SWKS).

AAPL

Apple

$160.86

-0.64 (-0.40%)

AVGO

Broadcom

$247.14

-0.6 (-0.24%)

CY

Cypress Semiconductor

$14.16

0.36 (2.61%)

IDTI

Integrated Device

$26.31

0.56 (2.17%)

SWKS

Skyworks

$106.87

-0.32 (-0.30%)

  • 13

    Sep

  • 25

    Sep

  • 05

    Oct

AAPL Apple
$160.86

-0.64 (-0.40%)

09/13/17
WEDB
09/13/17
NO CHANGE
WEDB
New iPhone sales unlikely 'substantially higher' than prior year, says Wedbush
WedBush analyst Michael Pachter notes that Apple's (AAPL) September 12 Special Event highlighted several planned introductions across its various product lines, including an iPhone with a new form factor and facial recognition technology. The analyst believes it is unlikely that sales will be substantially higher on this year's upgraded products versus the prior year given similar price points and release dates. However, the new wireless charging capability may drive incremental charger sales for Best Buy (BBY) and other retailers, he adds. Pachter also pointed out that GameStop (GME) is encouraging its customers to purchase one of the new iPhones by trading in an old phone or other electronic device at its stores.
09/13/17
STFL
09/13/17
NO CHANGE
STFL
Buy
Foldable smartphones another potential catalyst for Coherent, says Stifel
Stifel analyst Patrick Newton noted that AP reported yesterday that the President of Samsung's (SSNLF) mobile business said the company could release its anticipated foldable smartphone as soon as next year. Such a potential launch, and likely broader adoption of the technology by peers, is a potential long-term catalyst for Coherent (COHR) and other such equipment suppliers whose revenues are linearly correlated with total screen area, he tells investors. Also, higher resolution OLED displays, like the one confirmed yesterday for Apple's (AAPL) iPhone X, are a positive for Coherent's future recurring revenue from laser discharge units, added Newton, who keeps a Buy rating on Coherent shares.
09/13/17
KEYB
09/13/17
NO CHANGE
KEYB
Sector Weight
Apple iPhone X 'disappointing,' says KeyBanc
KeyBanc analyst Andy Hargreaves views Apple iPhone X launch event as largely neutral. The analyst was positively surprised by the Apple Watch functionality and the price increase on the iPhone 8 and 8 Plus, but was disappointed by the lack of incremental functionality in the iPhone X to justify the $999 price point. Hargreaves believes this raises the risk that future cycles will see trade-down behavior and correlated pricing pressure. He reiterates a Sector Weight rating on the shares.
09/13/17
UBSW
09/13/17
NO CHANGE
Target $180
UBSW
Buy
Apple shares reacting in-line with historical norm, says UBS
UBS analyst Steven Milunovich said Apple shares are performing in-line with the stock's history after the company conducted its product launch presentation - down into the event and up or down a bit the day of the event. Historically, what happens next is the stock will be down for a few weeks before moving up heading into earnings. The analyst admitted there were few surprises but the event was still impressive and he said the product pricing, which he views as pushing the envelope, was higher than he expected. Milunovich reiterated his Buy rating and $180 price target on Apple shares.
AVGO Broadcom
$247.14

-0.6 (-0.24%)

08/25/17
BARD
08/25/17
NO CHANGE
Target $290
BARD
Outperform
Broadcom price target raised to $290 from $260 at Baird
Baird analyst Tristan Gerra raised his price target on Broadcom to $290 from $260 following Q3 results. The analyst said the company will have significantly higher iPhone content, which is expected to drive strong momentum for the rest of 2017. The company already reached its operating margin target in the quarter but further momentum in its core business could help it expand further, said Gerra, who reiterated his Outperform rating on Broadcom shares.
08/25/17
CHLM
08/25/17
NO CHANGE
CHLM
Integrated Device has positive read through from Broadcom, says Craig-Hallum
Craig-Hallum analyst Tony Stoss says that Integrated Device (IDTI) has a positive read through from Broadcom's (AVGO) results. He notes that Broadcom said that its enterprise segment generated strong growth due to the release of Intel's (INTC) Purley chip. Stoss expects Integrated Device to also benefit from this catalyst, and he keeps a Buy rating on the stock.
09/12/17
JPMS
09/12/17
NO CHANGE
Target $315
JPMS
Overweight
JPMorgan still confident Apple will integrate Broadcom's wireless charging
Ahead of today's next generation iPhone announcement, JPMorgan analyst Harlan Sur says he remains confident that Apple (AAPL) will integrate Broadcom's (AGO) wireless charging chip into the next iPhone family in the second half of 2017. Broadcom commenced manufacturing production of the chip back in late June with its foundry partners, Sur tells investors in a research note. The analyst is also confident that Apple will also use Broadcom's next generation Wi-Fi/Bluetooth combo chip which enables simultaneous Wi-Fi data transmit/receive on both 2.4Ghz/5Ghz bands and the new Bluetooth 5.0 standard. He sees at least a $3-$4 step-up, or 40%-45% increase, in dollar content for Broadcom in the new iPhone relative to last year's models. Sur reiterates an Overweight rating on Broadcom with a $315 price target.
09/12/17
JPMS
09/12/17
NO CHANGE
JPMS
JPMorgan lays out iPhone content winners and losers into launch event
JPMorgan analyst Harlan Sur believes Apple's (AAPL) launch event today will be positive for Broadcom (AVGO) and Qorvo (QRVO) as well as Micron (MU) and Intel (INTC). The analyst sees content gains by Broadcom in wireless charging, touch controller, Wi-Fi/Bluetooth and GPS connectivity, and by Qorvo in low band power amplifier duplexers share and antenna tuning. Other companies with significant Apple exposure that would benefit from increased unit sales and/or modest content gains include Intel, Skyworks (SWKS), Knowles (KN), Micron, Cypress Semiconductor (CY), NXP Semiconductors (NXPI) and Texas Instruments (TXN), Sur tells investors in a research note. The analyst sees Analog Devices' (ADI) blended content at Apple declining as he believes the company will not be the touch controller for the OLED-version of the iPhone.
CY Cypress Semiconductor
$14.16

0.36 (2.61%)

08/17/17
KEYB
08/17/17
NO CHANGE
KEYB
Cypress Semiconductor outlook has improved, says KeyBanc
After meeting with Cypress' management, KeyBanc analyst John Vinh calls the company "one of his favorite names." The analyst says he is increasingly confident that the company's gross margin will reach 43% at the end of this year and is more confident in its ability to maintain its business with Apple (AAPL) "for multiple product cycles." He is also more confident in its ability to sell more of its chips for use in automobiles. Vinh keeps a $17 price target and an Overweight rating on Cypress.
08/18/17
KEYB
08/18/17
NO CHANGE
KEYB
Apple OLED iPhone to be hurt by lack of fingerprint sensor, says KeyBanc
KeyBanc analyst Andy Hargreaves,says that supplier checks indicate that Apple (AAPL) has not been able to add an optical fingerprint solution to its new OLED iPhone and has decided to ship the device without such a sensor. Hargreaves believes that this development will negatively impact the upcoming iPhone cycle and cause more bullish Apple investors to be disappointed. However, he is upbeat on the stock's risk/reward ratio in the near-term, as he thinks that "initial demand" for the OLED iPhone 8 will be strong. However, he remains upbeat on iPhone suppliers Broadcom (AVGO), Cirrus Logic (CRUS), Cypress Semiconductor (CY), and Skyworks (SWKS).
08/29/17
CHLM
08/29/17
NO CHANGE
Target $20
CHLM
Buy
Craig-Hallum still buyer of Cypress as Apple plans not to include fast charging
Craig-Hallum analyst Anthony Stoss says that based on checks, he believes Apple (AAPL) no longer plans to include a super-fast USB-C charging cord in the box for the upcoming iPhone launch, and has decided to go with a lower end/cheaper version of USB-C. Apple will only include a slower speed charging cord in the box at launch, he adds. Stoss points out that Cypress Semiconductor (CY) has USB-C content in both, but not including this technology in the box will impact upside to the coming quarters. The analyst is not changing his estimates as he had not factored in much from Apple until he could better handicap the impact from USB-C. He reiterates a Buy rating and $20 price target on Cypress shares.
IDTI Integrated Device
$26.31

0.56 (2.17%)

07/12/17
NEED
07/12/17
NO CHANGE
Target $43
NEED
Buy
Needham remains positive on Intel
After attending Intel's (INTC) official launch event for its Xeon Scalable Platform, Needham analyst N. Quinn Bolton says he came away positive on Intel's shares and expects the ramp to positively impact Cavium (CAVM), Integrated Device (IDTI), Monolithic Power (MPWR) and Microsemi (MSCC). The analyst reiterates a Buy rating and $43 price target on Intel's shares.
08/01/17
BOFA
08/01/17
DOWNGRADE
BOFA
Underperform
Integrated Device downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Vivek Arya downgraded Integrated Device to Underperform and maintained a $27 price target following the Q1 report citing "sluggish organic growth" and increased volatility from "lumpy demand" in smartphone, telecom, and data center markets. Arya sees FY19 sales growth at the lower end of management's 8%-10% target, creating downside risk to Street estimates.
09/11/17
CHLM
09/11/17
NO CHANGE
Target $30
CHLM
Buy
Craig-Hallum remains a buyer of Integrated Device
Craig-Hallum analyst Anthony Stoss says he would be a buyer of Integrated Device as shares remain cheap. The analyst believes the accelerating deployments of small cells are a positive trend for Integrated Device. Stoss looks for Integrated Device to see a flood of demand for their RF and timing products for small cells as deployments accelerate over the next several years. Moreover, demand for small cell related RF/timing products coupled with new RF chips for base stations allow Integrated Device to take share from competitors which should help offset a weak Communication's end market for the time being until 5G begins in late 2018 and beyond. The analyst reiterates Buy rating and $30 price target on the shares.
SWKS Skyworks
$106.87

-0.32 (-0.30%)

08/28/17
RSBL
08/28/17
NO CHANGE
RSBL
Skyworks may have lost Huawei share to Qorvo, says Rosenblatt
Rosenblatt said Skyworks (SWKS) may have lost share at Huawei this quarter and could potentially lose more share to Qorvo (QRVO) in both the Samsung Note 8 and Galaxy S9 due to PAM technical issues. The firm's analyst believes Skyworks share loss could impact the March quarter outlook.
09/05/17
SBSH
09/05/17
UPGRADE
Target $125
SBSH
Buy
Skyworks upgraded to Buy from Sell at Citi
Citi analyst Atif Malik double upgraded Skyworks Solutions to Buy from Sell and raised his price target for the shares to $125 from $90. The shares offer an "attractive play" on increasing RF semiconductor dollar content for 5G deployments, which should pick up over next three years, Malik tells investors in a research note titled "Backing up the Minivan; U/G to BUY on 5G Appeal & Stable Margins."
09/06/17
NOMU
09/06/17
INITIATION
Target $115
NOMU
Buy
Skyworks initiated with a Buy at Nomura Instinet
Nomura Instinet analyst Krysten Sciacca started Skyworks with a Buy rating and $115 price target. The analyst views the iPhone 8 launch as a catalyst in the second half of 2017 and thinks the stock at current levels underappreciates the company's longer term growth prospects.

TODAY'S FREE FLY STORIES

GM

General Motors

$39.42

0.32 (0.82%)

11:43
09/23/17
09/23
11:43
09/23/17
11:43
Periodicals
GM to eliminate shift at Tennessee SUV plant on 'moderating' sales, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.25

0.19 (0.35%)

11:34
09/23/17
09/23
11:34
09/23/17
11:34
Periodicals
Wells Fargo hires law firm to prepare CEO for Senate appearance, Reuters says »

Wells Fargo has hired law…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 13

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

EADSY

Airbus

$23.06

-0.01 (-0.04%)

11:27
09/23/17
09/23
11:27
09/23/17
11:27
Periodicals
Airbus in talks to sell all or part of Premium Aerotec, Reuters says »

Airbus is said to be in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$102.11

0.56 (0.55%)

11:06
09/23/17
09/23
11:06
09/23/17
11:06
Hot Stocks
Quest Diagnostics 'disappointed' with proposed PAMA 2018 Medicare payment rates »

Quest Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

IRBT

iRobot

$76.14

-3.8 (-4.75%)

10:58
09/23/17
09/23
10:58
09/23/17
10:58
Periodicals
iRobot suffering after onslaught of SharkNinja cheaper models, Barron's says »

In a follow up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47
Periodicals
Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says »

As everyday items get…

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UTX

United Technologies

$115.01

0.51 (0.45%)

, COL

Rockwell Collins

$130.48

0.09 (0.07%)

10:42
09/23/17
09/23
10:42
09/23/17
10:42
Periodicals
Major aircraft makers, suppliers face off, Barron's says »

While United Technologies…

UTX

United Technologies

$115.01

0.51 (0.45%)

COL

Rockwell Collins

$130.48

0.09 (0.07%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

GPRO

GoPro

$10.75

-0.19 (-1.74%)

10:33
09/23/17
09/23
10:33
09/23/17
10:33
Periodicals
Key events may create 'short squeeze' in GoPro stock, Barron's says »

GoPro, a heavily shorted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.91

0.18 (0.61%)

, RACE

Ferrari

$113.47

-0.1 (-0.09%)

10:17
09/23/17
09/23
10:17
09/23/17
10:17
Periodicals
Honda $200,000 Acura NSX lacks Ferrari 'raw appeal,' Barron's says »

Acura, Honda's (HMC)…

HMC

Honda

$29.91

0.18 (0.61%)

RACE

Ferrari

$113.47

-0.1 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.16

0.19 (0.40%)

10:07
09/23/17
09/23
10:07
09/23/17
10:07
Periodicals
Oracle shares could return 20% in a year, Barron's says »

Oracle is a latecomer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.96

1.14 (1.97%)

09:59
09/23/17
09/23
09:59
09/23/17
09:59
Periodicals
Six Flags may have peaked, Barron's says »

Investors have had an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

, AVXS

AveXis

$92.11

-4.03 (-4.19%)

09:51
09/23/17
09/23
09:51
09/23/17
09:51
Periodicals
Gene therapy may be nearing 'major breakthrough,' Baron's says »

Gene therapy is rapidly…

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

  • 22

    Sep

AET

Aetna

$153.57

0.18 (0.12%)

, ANTM

Anthem

$182.86

-0.64 (-0.35%)

09:25
09/23/17
09/23
09:25
09/23/17
09:25
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

AOBC

American Outdoor Brands

$15.01

-0.15 (-0.99%)

RGR

Sturm, Ruger

$51.00

-1.85 (-3.50%)

WMT

Wal-Mart

$79.53

-0.48 (-0.60%)

PEP

PepsiCo

$111.85

-0.95 (-0.84%)

TGT

Target

$58.99

0.66 (1.13%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

TWTR

Twitter

$17.61

0.03 (0.17%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 22

    Oct

  • 24

    Oct

  • 08

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

INSE

Inspired Entertainment

$13.60

0.3 (2.26%)

17:38
09/22/17
09/22
17:38
09/22/17
17:38
Hot Stocks
Inspired Entertainment COO Wilson leaving by reason of redundancy »

On September 21, Inspired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MNOV

MediciNova

$6.18

0.3 (5.10%)

17:30
09/22/17
09/22
17:30
09/22/17
17:30
Syndicate
Breaking Syndicate news story on MediciNova »

MediciNova files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ISRG

Intuitive Surgical

$1,031.52

1.31 (0.13%)

17:25
09/22/17
09/22
17:25
09/22/17
17:25
Conference/Events
Intuitive Surgical to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

GD

General Dynamics

$205.41

-0.31 (-0.15%)

17:21
09/22/17
09/22
17:21
09/22/17
17:21
Hot Stocks
General Dynamics Electric Boat awarded $341.2M government contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHRS

Coherus Biosciences

$12.85

0.3 (2.39%)

17:19
09/22/17
09/22
17:19
09/22/17
17:19
Syndicate
Breaking Syndicate news story on Coherus Biosciences »

Coherus Biosciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FIBK

First Interstate

$36.90

0.3 (0.82%)

17:18
09/22/17
09/22
17:18
09/22/17
17:18
Syndicate
First Interstate files to sell $250M of Class A common stock »

The shelf registration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

, NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

17:08
09/22/17
09/22
17:08
09/22/17
17:08
Hot Stocks
National Research launches metric to measure healthcare consumer loyalty »

NRC Health launched the…

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$51.79

-0.16 (-0.31%)

, HON

Honeywell

$141.75

0.89 (0.63%)

16:58
09/22/17
09/22
16:58
09/22/17
16:58
Hot Stocks
Chemours files appeal concerning SNAP 20 rule to regulate HFCs »

The Chemours Company (CC)…

CC

Chemours

$51.79

-0.16 (-0.31%)

HON

Honeywell

$141.75

0.89 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.